JP2015221783A5 - - Google Patents

Download PDF

Info

Publication number
JP2015221783A5
JP2015221783A5 JP2015091815A JP2015091815A JP2015221783A5 JP 2015221783 A5 JP2015221783 A5 JP 2015221783A5 JP 2015091815 A JP2015091815 A JP 2015091815A JP 2015091815 A JP2015091815 A JP 2015091815A JP 2015221783 A5 JP2015221783 A5 JP 2015221783A5
Authority
JP
Japan
Prior art keywords
skin
present
composition
composition according
foamable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015091815A
Other languages
Japanese (ja)
Other versions
JP5988406B2 (en
JP2015221783A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2015091815A priority Critical patent/JP5988406B2/en
Priority claimed from JP2015091815A external-priority patent/JP5988406B2/en
Publication of JP2015221783A publication Critical patent/JP2015221783A/en
Publication of JP2015221783A5 publication Critical patent/JP2015221783A5/ja
Application granted granted Critical
Publication of JP5988406B2 publication Critical patent/JP5988406B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明者らは、上記課題を解決するために、起泡性組成物について検討を繰り返した結果、水性溶媒(水および多価アルコール等)を70重量％以上含み、低級アルコールを含まない液状組成物に、起泡剤として二種類の界面活性剤を添加して調製した原液(発泡可能な液体組成物)によって、前記課題を解決できることを見い出し、本発明を完成した。 The present inventors have found that in order to solve the above problems, as a result of repeated studies for foaming composition comprising an aqueous solvent (water and polyhydric alcohol) 70% by weight or more, does not contain a lower alcohol It was found that the above problems could be solved by using a stock solution (foamable liquid composition) prepared by adding two types of surfactants as a foaming agent to a liquid composition, and completed the present invention.

本発明に係る起泡性組成物は、低級アルコール(エタノール等の炭素数1〜3の脂肪族一価アルコール)を含まないため、皮膚への刺激性が低い。したがって、本発明に係る起泡性組成物は、過敏な状態の皮膚(例えば乾燥やアトピー等によりバリア機能が低下した皮膚)を治療するための局所用医薬組成物として適している。本発明に係る組成物は特に、乾燥性皮膚疾患、アトピー性皮膚炎、乾癬等の皮膚疾患を治療するのに適している。 Since the foamable composition according to the present invention does not contain a lower alcohol (C1-C3 aliphatic monohydric alcohol such as ethanol), the irritation to the skin is low. Therefore, the foamable composition according to the present invention is suitable as a topical pharmaceutical composition for treating sensitive skin (for example, skin whose barrier function is reduced by drying, atopy, etc.). The composition according to the invention is particularly suitable for treating skin diseases such as dry skin diseases, atopic dermatitis, psoriasis.

JP2015091815A 2014-04-30 2015-04-28 Foaming composition Active JP5988406B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015091815A JP5988406B2 (en) 2014-04-30 2015-04-28 Foaming composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014093412 2014-04-30
JP2014093412 2014-04-30
JP2015091815A JP5988406B2 (en) 2014-04-30 2015-04-28 Foaming composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016139345A Division JP6507127B2 (en) 2014-04-30 2016-07-14 Foaming composition

Publications (3)

Publication Number Publication Date
JP2015221783A JP2015221783A (en) 2015-12-10
JP2015221783A5 true JP2015221783A5 (en) 2016-06-02
JP5988406B2 JP5988406B2 (en) 2016-09-07

Family

ID=54785032

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015091815A Active JP5988406B2 (en) 2014-04-30 2015-04-28 Foaming composition
JP2016139345A Active JP6507127B2 (en) 2014-04-30 2016-07-14 Foaming composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016139345A Active JP6507127B2 (en) 2014-04-30 2016-07-14 Foaming composition

Country Status (1)

Country Link
JP (2) JP5988406B2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5988406B2 (en) * 2014-04-30 2016-09-07 マルホ株式会社 Foaming composition
JP2016121145A (en) * 2014-12-24 2016-07-07 株式会社ポーラファルマ External composition for screen foamer
ES2946759T3 (en) * 2016-06-16 2023-07-25 Pola Pharma Inc Foam and sieve foaming composition
JP6928760B2 (en) * 2016-06-16 2021-09-01 サンファーマ株式会社 Foam, composition for screen formers, and how to evaluate them
CN110678168A (en) * 2017-05-31 2020-01-10 株式会社资生堂 Cosmetic preparation
JP7301536B2 (en) * 2018-12-25 2023-07-03 小林製薬株式会社 external composition
JPWO2020138403A1 (en) * 2018-12-27 2021-11-11 ライオン株式会社 External composition for skin and aerosol
WO2020161771A1 (en) * 2019-02-04 2020-08-13 マルホ株式会社 Skin composition
JP6884441B1 (en) * 2020-07-30 2021-06-09 アピ株式会社 Topical composition
JP2022060165A (en) * 2020-10-02 2022-04-14 花王株式会社 Carbonated aerosol topical skin application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2546794B2 (en) * 1987-01-26 1996-10-23 鐘紡株式会社 Foam self-injection lotion composition
JPH02123193A (en) * 1988-11-01 1990-05-10 Kao Corp Detergent composition
JPH0812517A (en) * 1994-06-29 1996-01-16 Kao Corp Foamable composition
AU2002251662B2 (en) * 2001-04-12 2005-04-21 Medicarb Ab An effervescent solid composition of matter
DK1809342T3 (en) * 2004-10-20 2015-08-17 Ethicon Inc absorbable hemostat
US8580860B2 (en) * 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
JP2013170145A (en) * 2012-02-21 2013-09-02 Kao Corp Skin cosmetic composition
JP5988406B2 (en) * 2014-04-30 2016-09-07 マルホ株式会社 Foaming composition

Similar Documents

Publication Publication Date Title
JP2015221783A5 (en)
CL2020002269A1 (en) Fold-Binding Antibody33; polynucleotide; vector; host cell; method of producing the antibody; pharmaceutical composition; combination product; use of the antibody to treat an inflammatory condition (divisional application no. 201702433)
CL2015002710A1 (en) Compositions of arni against component c5 of the complement and methods for its use.
MX2017004256A (en) Method of sanitizing edible seeds, particularly mucilage producing seeds.
BR112016022607B8 (en) POWDER AND METHOD TO IMPROVE TOPICAL APPLICATION OF MINOXIDIL
BR112016021023A8 (en) topical corticosteroid compositions
CO2018001375A2 (en) Topical retinoid compositions
CL2016000188A1 (en) Compositions of serpinc1 harness and methods of use thereof
BR112016022159B8 (en) POWDER AND METHOD TO IMPROVE TOPICAL APPLICATION OF A BENEFIT ACID AGENT
BR122021018243A8 (en) LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT
CL2019001447A1 (en) Preparation of solid cyclodextrin complexes for the supply of ophthalmic active pharmaceutical ingredients.
CY1121069T1 (en) BPO WASHING GEL COMPOSITION
BR112016011742A2 (en) CLEANING COMPOSITION WITH QUICK FOAM COLLAPSE
BR112016025126A2 (en) liquid formulation comprising gm-csf neutralizing compound
RS54131B1 (en) New pharmaceutical composition for the treatment of fungal infections
BR112016017897A8 (en) use of heterocyclic diamino carboxamide compound in the treatment of axl-related cancer, pharmaceutical composition and combination
MX2015013883A (en) Composition comprising cyclodextrin as uv- and ir-radiation screen agent.
ECSP15033898A (en) TOPICAL ANTIFUNGAL COMPOSITION FOR THE TREATMENT OF ONICHOMYCOSIS
DOP2019000099A (en) SUBSTITUTED DERIVATIVES OF 6- (1H-PIRAZOL-1-IL) PIRIMIDIN-4-AMINA AND USES OF THE SAME
JP2015034162A5 (en)
AR102008A1 (en) ACTIVE PHARMACEUTICAL INGREDIENT (IFA) OLEOUS FOR THE TREATMENT OF SKIN AFFECTIONS, COMPOSITIONS THAT INCLUDE IT AND ITS USE TO PREPARE THEM
MX2019000717A (en) Compositions comprising a polysaccharide matrix for the controlled release of active ingredients.
BR112018074576A2 (en) aqueous surfactant composition, and use thereof.
DOP2016000213A (en) TYPICAL ANTIFUNGICAL COMPOSITION FOR ONICOMYCOSIS TREATMENT
JP2018515575A5 (en)